Globus Medical (GMED) Asset Writedowns and Impairment (2011 - 2026)

Globus Medical's Asset Writedowns and Impairment history runs 16 years deep, the most recent figure standing at $5.0 million for Q1 2026.

• Quarterly Asset Writedowns and Impairment fell 16.78% year-over-year to $5.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.2 million (down 65.0% YoY) and the FY2025 annual result came in at $10.2 million, down 56.24% from the prior year.
• Asset Writedowns and Impairment was $5.0 million for Q1 2026 at Globus Medical, up from $4.9 million in the prior quarter.
• Across five years, Asset Writedowns and Impairment topped out at $8.5 million in Q2 2024 and bottomed at -$5.9 million in Q4 2022.
• A 5-year average of $2.5 million and a median of $3.2 million in 2023 frame the typical range for Asset Writedowns and Impairment.
• Annual changes were most pronounced in 2024 — Asset Writedowns and Impairment jumped 1410.58% — and 2025, when it tumbled 219.29%.
• Globus Medical's Asset Writedowns and Impairment stood at -$5.9 million in 2022, then jumped by 89.37% to -$626000.0 in 2023, then soared by 1244.57% to $7.2 million in 2024, then slumped by 31.44% to $4.9 million in 2025, then advanced by 0.98% to $5.0 million in 2026.
• Business Quant data shows GMED's Asset Writedowns and Impairment at $5.0 million in Q1 2026, $4.9 million in Q4 2025, and -$5.6 million in Q3 2025.